Skyepharma

Through many years of involvement and achievements in the pharmaceutical industry, Skyepharmas development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms. We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services. Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial manufacturing and packaging activities. Our value proposal includes tailored services to clients requirements supporting them...

Scale up,manufacturing of clinical trial materials,technology transfer,bulk manufacturing,analytical development,packaging,formulation and process development,quality,serialization,cdmo,cmo,multi-layer tablet,tab in tab,oral solid dosage form,quality by design,regulatory,controlled release,aggregation,fda approved,life cycle management,external manufacturing,one stop shop,and cro

Skyepharma operates in the Pharmaceutical manufacturing industry.

Skyepharma's revenue is 11m - 100m

Skyepharma has 201 - 500 employees.